Cannabinoid Type 2 (CB(2)) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease

The cannabinoid type two receptors (CB(2)), an important component of the endocannabinoid system, have recently emerged as neuromodulators and therapeutic targets for neurodegenerative diseases including Parkinson's disease (PD). The downregulation of CB(2) receptors has been reported in the br...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Neurosci
Päätekijät: Javed, Hayate, Azimullah, Sheikh, Haque, M. Emdadul, Ojha, Shreesh K.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2016
Aiheet:
Psychiatry
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4969295/
https://ncbi.nlm.nih.gov/pubmed/27531971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnins.2016.00321
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia